May & Baker Limited

Active02450361 Private limited company

Incorporated: 7 December 1989 (36 years)
Previously known as: May & Baker Pharmaceuticals Limited (until 16 December 1991)
Figcroft Limited (until 20 March 1991)
Industry: Other business support service activities n.e.c. (82990)
Directors: Walaa Mostafa Abbas Awad Mohamed
Ahmed Mohamed Moustafa Moussa
Owned by: Aventis Pharma Limited
Accounts type: Full
Region: South East
Address: 410 Thames Valley Park Drive
Reading
RG6 1PT

Filing status

Accounts due: 30 September 2027
Last accounts: 31 December 2025
Conf. stmt due: 14 January 2027
Last conf. stmt: 31 December 2025

Officers 2 active

Officer details are public data from the Companies House register.

Mohamed, Walaa Mostafa Abbas Awad

Director · Appointed 1 February 2026

Also at Blueprint Medicines (UK) Ltd., Fisons Limited, Rhone-Poulenc Rorer Limited · more companies

Egyptian

Born October 1977 (49)

Moussa, Ahmed Mohamed Moustafa

Director · Appointed 1 February 2026

Also at Genzyme Therapeutics Limited, RPR (US) Limited, Aventis Pharma Limited · more companies

Egyptian

Born August 1984 (42)

Officer history (35 former)

1 February 2026

Resigned Khan, Usman as Director

1 February 2026

Appointed Moussa, Ahmed Mohamed Moustafa as Director

1 February 2026

Resigned Ubhi, Rippondeep as Director

1 February 2026

Appointed Mohamed, Walaa Mostafa Abbas Awad as Director

1 March 2024

Appointed Ubhi, Rippondeep as Director

1 March 2024

Resigned Baird, Jessamy Rachel as Director

19 August 2021

Appointed Baird, Jessamy Rachel as Director

19 August 2021

Resigned Tillett, Gordon Michael as Director

31 March 2021

Appointed Khan, Usman as Director

31 March 2021

Resigned Fry, Hugo Rupert Alexander as Director

31 March 2021

Resigned Duhalde, Francois-Xavier as Director

31 March 2021

Appointed Tillett, Gordon Michael as Director

1 January 2017

Appointed Fry, Hugo Rupert Alexander as Director

30 September 2016

Resigned Stenvall, Tarja Johanna as Director

1 April 2016

Resigned Prosser, Andrew Michael James as Director

1 April 2016

Appointed Duhalde, Francois-Xavier as Director

19 November 2014

Appointed Stenvall, Tarja Johanna as Director

25 July 2014

Resigned Oldfield, Stephen Philip as Director

1 October 2010

Resigned Mcclellan, Michael James as Director

1 September 2010

Appointed Prosser, Andrew Michael James as Director

12 May 2010

Appointed Oldfield, Stephen Philip as Director

12 May 2010

Resigned Mcclellan, Michael James as Secretary

12 May 2010

Resigned Brooksby, Nigel Stanley as Director

13 February 2008

Appointed Mcclellan, Michael James as Secretary

30 January 2008

Resigned Roberts, Helen as Secretary

16 November 2007

Appointed Mcclellan, Michael James as Director

16 November 2007

Resigned De Forceville, Guillaume Adrien as Director

20 December 2004

Appointed Roberts, Helen as Secretary

20 December 2004

Resigned Smith, Suzanne Elaine as Secretary

8 November 2004

Resigned Chancel, Pierre as Director

8 November 2004

Appointed Brooksby, Nigel Stanley as Director

8 November 2004

Appointed De Forceville, Guillaume Adrien as Director

8 November 2004

Resigned Nicholls, David John as Director

8 November 2004

Resigned Rees, David Hugh Thomas as Director

19 May 2004

Appointed Chancel, Pierre as Director

25 February 2004

Resigned Nicholls, David John as Secretary

23 February 2004

Appointed Smith, Suzanne Elaine as Secretary

12 September 2003

Resigned Whelan, Anthony John as Director

13 December 2002

Resigned Mitchum, James Paul as Director

30 June 2001

Appointed Nicholls, David John as Secretary

30 June 2001

Resigned Clapham, Christopher Edward as Secretary

24 March 2000

Resigned Hemingway, Roger Barry as Director

18 February 2000

Appointed Clapham, Christopher Edward as Secretary

18 February 2000

Resigned Nicholls, David John as Secretary

4 February 2000

Appointed Whelan, Anthony John as Director

13 January 2000

Resigned Abrehart, David Charles as Director

10 January 2000

Appointed Rees, David Hugh Thomas as Director

16 December 1999

Appointed Mitchum, James Paul as Director

1 October 1999

Appointed Abrehart, David Charles as Director

1 October 1999

Resigned Aulagnon, Marie-Christine Gisele as Director

31 January 1999

Resigned Michelmore, John Douglas as Director

30 September 1998

Resigned Stanton, Frances Louise as Director

20 May 1998

Resigned Allington, Timothy James as Director

18 May 1998

Appointed Hemingway, Roger Barry as Director

4 December 1997

Resigned Colquhoun, Richard Lyons as Director

30 April 1997

Resigned Blinman, Peter as Director

7 April 1997

Appointed Aulagnon, Marie-Christine Gisele as Director

4 October 1996

Resigned Harris, Michael John as Director

4 October 1996

Resigned Harris, Michael John as Secretary

4 October 1996

Appointed Nicholls, David John as Director

4 October 1996

Appointed Nicholls, David John as Secretary

28 February 1995

Resigned Bertrand, Jean-Jacques, Monsieur as Director

31 March 1994

Resigned Salenger, Keith Philip as Director

14 December 1993

Appointed Blinman, Peter as Director

1 February 1993

Appointed Harris, Michael John as Director

1 February 1993

Appointed Salenger, Keith Philip as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Aventis Pharma Limited

Corporate entity · Notified 25 January 2021

Owns 75–100% of shares

Holds 75–100% of voting rights

Right to appoint and remove directors

Private Limited Company

Reg. no. 01535640

Former controllers (1)

25 January 2021

Ceased Sanofi-Aventis UK Holdings Limited — Owns 75–100% of shares

Group structure 7 companies

Ownership group derived from the Companies House PSC register

Aventis Pharma Holdings Limited

Sanofi-Aventis Pensions Trust Limited Owns 75–100% of shares

Sanofi-Aventis UK Holdings Limited Owns 50–75% of shares

Aventis Pharma Limited Owns 75–100% of shares

Fisons Limited Owns 75–100% of shares

Genzyme Therapeutics Limited Owns 75–100% of shares

May & Baker Limited This company Owns 75–100% of shares

Filings 214

Date	Description	Made Up To
11 August 2026	Full accounts	31 December 2025
5 February 2026	Appointment of a director
5 February 2026	Appointment of a director
5 February 2026	Termination of appointment of a director
5 February 2026	Termination of appointment of a director